On July 18, 2025, the European Commission released its guidelines on the obligations for providers of general-purpose AI (GPAI) models under the European Union’s AI Act. This is an important development for companies, including in the Life Sciences sector, building their own GPAI models, as well as using, integrating and/or further developing third-party GPAI as
More Posts
The European Commission Publishes an EU Life Sciences Strategy
EU Consults on New GMP Rules for AI in Pharma Manufacturing
European Data Protection Board publishes study on secondary use of personal health data for scientific research
The Convergence of Life Sciences and Artificial Intelligence: Seizing Opportunities While Managing Risk
EMA adopts reflection paper on the use of Artificial Intelligence (AI)
AI: EMA publishes guiding principles on the use of large language models (LLMs)
The EU AI Act: Impact on the Life Sciences Industry
Commission Communication on biotechnology and biomanufacturing
Subscribe: Subscribe via RSS
Blogs
Firm/Org